Helix PartnersMUSC and Helix launch In Our DNA SC, first-of-its-kind population genomics program to drive preventive, precision health care for South CaroliniansSeptember 20, 2021
Population GenomicsIdentifying New Gene-Disease Associations for Population ScreeningSeptember 9, 2021
Helix PartnersHelix Study Identifies Additional Genes for Population Genetic ScreeningAugust 18, 2021
Helix PartnersPositive predictive value highlights four novel candidates for actionable genetic screening from analysis of 220,000 clinicogenomic recordsAugust 12, 2021
Helix ResearchOne of the largest gene-based collapsing analyses reveals potential candidate genes for population screeningAugust 3, 2021
Company NewsHelix Announces $50 Million Series C Funding to Continue Acceleration into Clinical Population Genomics and COVID-19 Viral SurveillanceJune 3, 2021
Helix PartnersPathogenic variants in actionable MODY genes are associated with type 2 diabetesOctober 11, 2020
Helix PartnersSaliva is less sensitive than nasopharyngeal swabs for COVID-19 detection in the community settingMay 15, 2020
Public HealthSaliva-based COVID-19 testing is less sensitive than nasopharyngeal swabs in the community settingMay 15, 2020
Helix PartnersGenome-wide rare variant analysis for thousands of phenotypes in over 70,000 exomes from two cohortsJanuary 28, 2020
